Stay updated on Pembrolizumab for Leukoplakia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The 403 page has been replaced by the ClinicalTrials.gov record for a phase II pembrolizumab study for leukoplakia, with details on eligibility, locations, study design, and outcomes.
    Difference
    51%
    Check dated 2026-11-08T05:25:13.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:24:29.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces transition updates and says agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The study page itself remains a 403 error.
    Difference
    1%
    Check dated 2026-10-25T02:28:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T02:15:16.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-11T03:23:49.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Access to the study record is blocked, with the page now displaying a 403 Forbidden error instead of the study details. The error page includes the typical site header and footer.
    Difference
    18%
    Check dated 2026-09-20T01:12:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.